CO4980884A1 - Tienopirimidinas - Google Patents

Tienopirimidinas

Info

Publication number
CO4980884A1
CO4980884A1 CO98070308A CO98070308A CO4980884A1 CO 4980884 A1 CO4980884 A1 CO 4980884A1 CO 98070308 A CO98070308 A CO 98070308A CO 98070308 A CO98070308 A CO 98070308A CO 4980884 A1 CO4980884 A1 CO 4980884A1
Authority
CO
Colombia
Prior art keywords
atoms
hal
alkylene
represent
groups
Prior art date
Application number
CO98070308A
Other languages
English (en)
Spanish (es)
Inventor
Jonas Rochus
Pierre Schelling
Kluxen Franz-Werner
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CO4980884A1 publication Critical patent/CO4980884A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO98070308A 1997-11-28 1998-11-27 Tienopirimidinas CO4980884A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752952A DE19752952A1 (de) 1997-11-28 1997-11-28 Thienopyrimidine

Publications (1)

Publication Number Publication Date
CO4980884A1 true CO4980884A1 (es) 2000-11-27

Family

ID=7850200

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98070308A CO4980884A1 (es) 1997-11-28 1998-11-27 Tienopirimidinas

Country Status (24)

Country Link
US (2) US6420368B1 (https=)
EP (1) EP1036078B1 (https=)
JP (1) JP4314341B2 (https=)
KR (1) KR20010032445A (https=)
CN (1) CN1138780C (https=)
AR (1) AR010962A1 (https=)
AT (1) ATE361926T1 (https=)
AU (1) AU742433B2 (https=)
BR (1) BR9815409A (https=)
CA (1) CA2311922C (https=)
CO (1) CO4980884A1 (https=)
CZ (1) CZ291068B6 (https=)
DE (2) DE19752952A1 (https=)
ES (1) ES2285796T3 (https=)
HK (1) HK1038924A1 (https=)
HU (1) HUP0100488A3 (https=)
ID (1) ID24571A (https=)
NO (1) NO20002702D0 (https=)
PL (1) PL341156A1 (https=)
RU (1) RU2217431C2 (https=)
SK (1) SK7772000A3 (https=)
TW (1) TW472059B (https=)
WO (1) WO1999028325A1 (https=)
ZA (1) ZA9810845B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
CN1346358A (zh) 1999-03-30 2002-04-24 日本曹达株式会社 噻吩并嘧啶化合物及其盐和制备方法
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
US20020006926A1 (en) 2000-04-19 2002-01-17 Roylance H. H. Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of parkinson's disease
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10042997A1 (de) * 2000-09-01 2002-03-14 Merck Patent Gmbh Thienopyrimidine
CA2423981A1 (en) * 2000-09-29 2003-03-28 Kimiko Ichikawa Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
AU2002227957A1 (en) * 2000-12-19 2002-07-01 Merck Patent Gmbh Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DE10064994A1 (de) * 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
HUP0302987A2 (hu) * 2001-01-31 2003-12-29 Merck Patent Gmbh Pirazolo [4,3-d] pirimidinszármazékokat vagy tienopirimidinszármazékokat és nitrátvegyületeket tartalmazó gyógyászati készítmények
MXPA03009925A (es) * 2001-04-30 2004-06-30 Bayer Pharmaceuticals Corp Nuevas tiofeno [2,3-d]pirimidinas 4-amino-5,6-sustituidas.
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
OA13050A (en) 2003-04-29 2006-11-10 Pfizer Ltd 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
CA2562251C (en) 2004-04-07 2009-04-28 Pfizer Inc. Pyrazolo'4,3-d pyrimidines
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
ES2259891B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259892B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
AR088218A1 (es) 2011-07-19 2014-05-21 Infinity Pharmaceuticals Inc Compuestos heterociclicos utiles como inhibidores de pi3k
CN109297923A (zh) * 2018-09-19 2019-02-01 南通出入境检验检疫局检验检疫综合技术中心 纺织品中微量含氟整理剂的测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE245666C (https=)
DD245666A1 (de) * 1985-09-20 1987-05-13 Univ Halle Wittenberg Verfahren zur herstellung von 4-aminosubstituierten thieno 2,3-d-pyrimidin-2-ylessigsaeureestern
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
CZ20001962A3 (cs) 2002-01-16
DE59814003D1 (en) 2007-06-21
WO1999028325A1 (de) 1999-06-10
ES2285796T3 (es) 2007-11-16
ZA9810845B (en) 1999-05-26
CZ291068B6 (cs) 2002-12-11
ID24571A (id) 2000-07-27
CN1306534A (zh) 2001-08-01
CA2311922C (en) 2009-09-29
JP2001525325A (ja) 2001-12-11
NO20002702L (no) 2000-05-26
RU2217431C2 (ru) 2003-11-27
JP4314341B2 (ja) 2009-08-12
PL341156A1 (en) 2001-03-26
HUP0100488A3 (en) 2003-03-28
EP1036078B1 (de) 2007-05-09
HK1038924A1 (zh) 2002-04-04
AU1962599A (en) 1999-06-16
DE19752952A1 (de) 1999-06-02
SK7772000A3 (en) 2000-12-11
EP1036078A1 (de) 2000-09-20
CA2311922A1 (en) 1999-06-10
TW472059B (en) 2002-01-11
AR010962A1 (es) 2000-07-12
HUP0100488A2 (hu) 2001-09-28
AU742433B2 (en) 2002-01-03
KR20010032445A (ko) 2001-04-25
NO20002702D0 (no) 2000-05-26
US6420368B1 (en) 2002-07-16
ATE361926T1 (de) 2007-06-15
BR9815409A (pt) 2000-10-24
US20020132818A1 (en) 2002-09-19
CN1138780C (zh) 2004-02-18
US6495554B2 (en) 2002-12-17

Similar Documents

Publication Publication Date Title
CO4980884A1 (es) Tienopirimidinas
CO5011050A1 (es) Tienopirimidinas
DE69213216D1 (de) Quarternäre panthenolderivate und ihre verwendung
ECSP941118A (es) Agentes de invercion mdr
AR063786A1 (es) Derivados de 1,4 -benzotiepina-1,1 dioxido sustituidos con radicales bencilo, productos farmaceuticos que comprenden estos compuestos y su uso
NO930817D0 (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
FI911330A0 (fi) 1,4,7,10-tetra-azacyklododekan -butyltrioler, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
AR039689A1 (es) Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
AR009212A1 (es) Un derivado de 3-piperidil-4-oxoquinazolina; una composicion farmaceutica, un inhibidor de la proteina de transferencia de los trigliceridos microsomal(mtp) y un agente terapeutico o preventivo para la hiperlipemia o la arteriosclerosis que lo contienen
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
DE69618231D1 (de) TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER
ES2062558T3 (es) Compuestos contra el cancer.
AR028914A1 (es) 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3
CA2063938A1 (en) Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
PA8483901A1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida
ES2189766T3 (es) Pyrazolo (4,3-d)ipiridmidinas.
ES2182401T3 (es) Derivados de amida y urea, como inhibidores de reabsorcion de 5-ht y como ligandos de 5-ht1b/1d.
ES2149742T1 (es) Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
CO4520229A1 (es) Derivados de la oxazolidin-2-ona y procedimiento para su obtencion
PT1000034E (pt) 6-alquilfenantridinas substituidas
ES2087730T3 (es) Empleo de los derivados de fenotiazina en el tratamiento de la isquemia y/o de la hipoxia.
SE7706346L (sv) Bensaminderivat
DE68906965D1 (de) Analgetische phenothiazinderivate.
FI923071L (fi) Staongkomposition innehaollande natriumklorid och stearylalkohol
CO4650180A1 (es) Derivados de alquil-5-metilsulfonil-benzoilguanidinas